JP2011506511A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2011506511A5 JP2011506511A5 JP2010538453A JP2010538453A JP2011506511A5 JP 2011506511 A5 JP2011506511 A5 JP 2011506511A5 JP 2010538453 A JP2010538453 A JP 2010538453A JP 2010538453 A JP2010538453 A JP 2010538453A JP 2011506511 A5 JP2011506511 A5 JP 2011506511A5
- Authority
- JP
- Japan
- Prior art keywords
- muscle
- cosmetic treatment
- agent according
- type
- therapeutic agent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US901007P | 2007-12-21 | 2007-12-21 | |
| EP07024961A EP2072039A1 (en) | 2007-12-21 | 2007-12-21 | Use of a neurotoxic component of Clostridium botulinum toxin complex to reduce or prevent side effects |
| PCT/EP2008/010782 WO2009080272A1 (en) | 2007-12-21 | 2008-12-17 | Use of a neurotoxic component of a clostridium botulinum toxin complex to reduce or prevent side effects |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2011506511A JP2011506511A (ja) | 2011-03-03 |
| JP2011506511A5 true JP2011506511A5 (enExample) | 2012-01-05 |
Family
ID=39401018
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010538453A Pending JP2011506511A (ja) | 2007-12-21 | 2008-12-17 | 副作用を軽減または防止するためのボツリヌス菌毒素複合体の神経毒成分の使用 |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20100331259A1 (enExample) |
| EP (2) | EP2072039A1 (enExample) |
| JP (1) | JP2011506511A (enExample) |
| KR (1) | KR20100107475A (enExample) |
| CN (1) | CN101917960A (enExample) |
| AR (1) | AR069806A1 (enExample) |
| AU (1) | AU2008340713A1 (enExample) |
| CA (1) | CA2709644A1 (enExample) |
| IL (1) | IL206423A0 (enExample) |
| MX (1) | MX2010006731A (enExample) |
| RU (1) | RU2010130542A (enExample) |
| WO (1) | WO2009080272A1 (enExample) |
| ZA (1) | ZA201004393B (enExample) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10792344B2 (en) * | 2006-06-29 | 2020-10-06 | Merz Pharma Gmbh & Co. Kgaa | High frequency application of botulinum toxin therapy |
| US9161970B2 (en) * | 2007-12-12 | 2015-10-20 | Allergan, Inc. | Dermal filler |
| US9480731B2 (en) * | 2013-12-12 | 2016-11-01 | Medy-Tox, Inc. | Long lasting effect of new botulinum toxin formulations |
| US11484580B2 (en) | 2014-07-18 | 2022-11-01 | Revance Therapeutics, Inc. | Topical ocular preparation of botulinum toxin for use in ocular surface disease |
| US9901627B2 (en) | 2014-07-18 | 2018-02-27 | Revance Therapeutics, Inc. | Topical ocular preparation of botulinum toxin for use in ocular surface disease |
| WO2018146550A1 (en) * | 2017-02-10 | 2018-08-16 | De Maio Domingos Mauricio | Methods and systems for preventing, correcting, transforming, and modifying facial, aesthetics, and consulting patients regarding the same |
| DE102019215585B4 (de) * | 2019-10-10 | 2022-02-17 | KCM Egészségügyi és Tudományos Korlátolt Felelösségü Társaság | Verfahren zur prävention von strahlenschäden in humanen drüsen |
| US11241479B2 (en) | 2019-10-18 | 2022-02-08 | Penland Foundation | Treatment methods using botulinum toxins |
| US10973873B1 (en) | 2019-10-18 | 2021-04-13 | Penland Foundation | Treatment of asthma using botulinum toxin |
| US11090371B1 (en) * | 2019-10-18 | 2021-08-17 | Penland Foundation | Treatment of cirrhosis using botulinum toxin |
| US11925677B2 (en) | 2021-07-12 | 2024-03-12 | Penland Foundation | Treatment of diabetes and chronic pancreatitis using botulinum toxin |
| US10967052B1 (en) | 2019-10-18 | 2021-04-06 | Penland Foundation | Treatment of dyslexia using botulinum toxin |
| AU2020365148B2 (en) | 2019-10-18 | 2022-10-27 | Penland Foundation | Botulinum toxin for use in treatment |
| US11738071B2 (en) | 2021-07-12 | 2023-08-29 | Penland Foundation | Treatment of acute and chronic kidney disease |
| US10987411B1 (en) | 2019-10-18 | 2021-04-27 | Penland Foundation | Treatment of chronic obstructive pulmonary disease using botulinum toxin |
| US10960061B1 (en) * | 2019-10-18 | 2021-03-30 | Penland Foundation | Treatment of amyotrophic lateral sclerosis using botulinum toxin |
| US10960060B1 (en) | 2019-10-18 | 2021-03-30 | Penland Foundation | Treatment of cardiac arrhythmia using botulinum toxin |
| KR102397708B1 (ko) * | 2020-04-29 | 2022-05-16 | 한국화학연구원 | 탄닌산을 포함하는 보툴리눔 독소 약제학적 조성물 |
| CN116096399A (zh) * | 2020-06-03 | 2023-05-09 | 米奥托克斯有限责任公司 | 用于治疗偏头痛病症的区带性和靶向方法和用途 |
| IL298399A (en) * | 2020-06-05 | 2023-01-01 | Merz Pharma Gmbh & Co Kgaa | Treatment of facial wrinkles with the botulinum toxin in high dose and low volume |
| KR102724650B1 (ko) | 2021-07-05 | 2024-11-01 | 주식회사 파마리서치바이오 | 클로스트리디움 보툴리눔 독소 복합체 단백질의 정제방법 |
| KR102724651B1 (ko) | 2021-07-08 | 2024-11-01 | 주식회사 파마리서치바이오 | 비-독소 단백질이 제거된 클로스트리디움 보툴리눔 신경독소 단백질의 정제방법 |
| KR102551301B1 (ko) | 2022-10-28 | 2023-07-03 | 주식회사 파마리서치바이오 | 보툴리눔 독소를 포함하는 안정한 액상 제제 |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8187612B2 (en) * | 1993-12-28 | 2012-05-29 | Allergan, Inc. | Use of the neurotoxic component of a botulinum toxin for treating a spastic muscle |
| EP1602379A1 (en) * | 1993-12-28 | 2005-12-07 | Allergan, Inc. | Botulinum toxin B for treating spastic muscle |
| US5512547A (en) * | 1994-10-13 | 1996-04-30 | Wisconsin Alumni Research Foundation | Pharmaceutical composition of botulinum neurotoxin and method of preparation |
| US5756468A (en) * | 1994-10-13 | 1998-05-26 | Wisconsin Alumni Research Foundation | Pharmaceutical compositions of botulinum toxin or botulinum neurotoxin and methods of preparation |
| DE19925739A1 (de) * | 1999-06-07 | 2000-12-21 | Biotecon Ges Fuer Biotechnologische Entwicklung & Consulting Mbh | Therapeutikum mit einem Botulinum-Neurotoxin |
| CA2494241C (en) | 2000-02-08 | 2011-06-14 | Allergan, Inc. | Botulinum toxin pharmaceutical compositions |
| US6503653B2 (en) * | 2001-02-23 | 2003-01-07 | General Motors Corporation | Stamped bipolar plate for PEM fuel cell stack |
| JP3830766B2 (ja) * | 2001-03-09 | 2006-10-11 | 本田技研工業株式会社 | 燃料電池および燃料電池スタック |
| EP1491205A4 (en) * | 2002-03-29 | 2007-04-25 | Chemo Sero Therapeut Res Inst | MEANS FOR THE TREATMENT OF HYPERMYOTONIA |
| US20040115222A1 (en) * | 2002-09-06 | 2004-06-17 | Michael Kane | Method for reduction of wrinkles |
| JP2005089336A (ja) * | 2003-09-12 | 2005-04-07 | Tokyo Univ Of Agriculture | Ｄ型ボツリヌス神経毒素の精製法 |
| BRPI0513850A (pt) * | 2004-07-26 | 2008-05-20 | Merz Pharma Gmbh & Co Kgaa | composição terapêutica com uma neurotoxina botulìnica |
| GB2426702A (en) * | 2004-10-28 | 2006-12-06 | Ipsen Ltd | Pharmaceutical composition comprising botulinum neurotoxin |
| DE102004043009A1 (de) * | 2004-09-06 | 2006-03-23 | Toxogen Gmbh | Transportprotein zum Einbringen chemischer Verbindungen in Nervenzellen |
| DE102005019302A1 (de) | 2005-04-26 | 2006-11-16 | Toxogen Gmbh | Carrier zum Targeting von Nervenzellen |
| AR061669A1 (es) | 2006-06-29 | 2008-09-10 | Merz Pharma Gmbh & Co Kgaa | Aplicacion de alta frecuencia de terapia con toxina botulinica |
-
2007
- 2007-12-21 EP EP07024961A patent/EP2072039A1/en not_active Withdrawn
-
2008
- 2008-12-17 US US12/735,144 patent/US20100331259A1/en not_active Abandoned
- 2008-12-17 CN CN2008801218887A patent/CN101917960A/zh active Pending
- 2008-12-17 KR KR1020107016383A patent/KR20100107475A/ko not_active Withdrawn
- 2008-12-17 EP EP08864233A patent/EP2231107A1/en not_active Withdrawn
- 2008-12-17 MX MX2010006731A patent/MX2010006731A/es not_active Application Discontinuation
- 2008-12-17 WO PCT/EP2008/010782 patent/WO2009080272A1/en not_active Ceased
- 2008-12-17 CA CA2709644A patent/CA2709644A1/en not_active Abandoned
- 2008-12-17 JP JP2010538453A patent/JP2011506511A/ja active Pending
- 2008-12-17 RU RU2010130542/15A patent/RU2010130542A/ru not_active Application Discontinuation
- 2008-12-17 AU AU2008340713A patent/AU2008340713A1/en not_active Abandoned
- 2008-12-18 AR ARP080105529A patent/AR069806A1/es not_active Application Discontinuation
-
2010
- 2010-06-16 IL IL206423A patent/IL206423A0/en unknown
- 2010-06-22 ZA ZA2010/04393A patent/ZA201004393B/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2011506511A5 (enExample) | ||
| RU2010130542A (ru) | Применение нейротоксичного компонента комплекса ботулинического токсина бактерий рода clostridium для уменьшения или предупреждения побочных эффектов | |
| Mazzuco et al. | Gummy smile and botulinum toxin: a new approach based on the gingival exposure area | |
| JP2009541396A5 (enExample) | ||
| NZ575334A (en) | Cosmetic composition for the treatment of skin and methods thereof | |
| Abdelatief | Effect of transcutaneous electrical nerve stimulation and faradic current stimulation on the recovery of Bell’s palsy | |
| Hexsel et al. | Botulinum toxin type A for aging face and aesthetic uses | |
| Tamura | Topografia facial das áreas de injeção de preenchedores e seus riscos | |
| Muhammad et al. | Comparison of efficacy of platelet-rich plasma (PRP) with PRP microneedling in androgenetic alopecia | |
| Carruthers et al. | Practical cosmetic Botox techniques | |
| Almeida et al. | Ácido hialuronico no rejuvenescimento do terço superior da face: revisão e atualização. Parte 2: regiões temporal e supraórbitária | |
| CN205659123U (zh) | 一种护眼用的按摩仪 | |
| Li et al. | Types of periocular wrinkles based on anatomical and contractile characteristics of participating periocular muscles: A modified classification method and personalized injection technique. | |
| Wang et al. | Enhancing Facial Projection: Efficacy and Safety of a Novel Filler Combining Cross‐Linked Sodium Hyaluronate Gel With Poly‐L‐Lactic Acid‐b‐PEG Microspheres for T‐Zone Augmentation | |
| Berry | Botulinum Toxin in Clinical Practice | |
| Redaelli et al. | International expert consensus on the use of AboBotulinum Toxin A (AboTA) for facial rejuvenation and primary hyperhidrosis | |
| CN107744458A (zh) | 一种头部古法拨筋技术 | |
| Peng | Masseter Hypertrophy: Toxin Treatment Techniques, Causes of Complications, and Prevention | |
| Moon et al. | Long-pulsed Alexandrite Laser vs. Intense pulsed light for axillary hair removal in Korean women | |
| Wang et al. | Hyperhidrosis and aesthetics | |
| Cervelli et al. | A glimpse into plastic surgery during COVID-19 pandemic | |
| Spencer | Facial anatomy and the use of botulinum toxin | |
| Seo | Hyperhidrosis Treatment with Botulinum Toxin | |
| Glaser | Botulinum toxin in the management of focal hyperhidrosis | |
| CN110022851A (zh) | 非治疗方法、刺激或产生体积增加的物质的用途 |